KaMoZo Biologics, Inc.

(Est. 2025)

Dis­cov­er Ground­break­ing Tech­nolo­gies

Novel Intracellular Cancer Therapies

Our over­ar­ch­ing goal is to rev­o­lu­tion­ize can­cer ther­a­py, trans­form­ing it from a life-threat­en­ing dis­ease into a man­age­able con­di­tion through the use of con­ve­nient dai­ly treat­ment.

Our can­cer ther­a­pies uti­lize advanced tech­nol­o­gy to tar­get onco­genic sig­nal­ing to the cel­l’s nucle­us which dis­rupts can­cer cells’ cycles and pre­vents tumor growth.

Rapid Intracellular Drug Delivery

Our intra­cel­lu­lar drug deliv­ery tech­nol­o­gy uti­lizes phys­i­o­log­ic sequences to pre­vent advert reac­tion includ­ing devel­op­ment of drug resis­tance. Our cell pen­e­trat­ing pep­tides have the abil­i­ty to cross plas­ma mem­brane bypass­ing endo­so­mal path­ways and pre­vent­ing the expo­sure of deliv­ered ther­a­peu­tic to lyso­so­mal degra­da­tion.